发明名称 |
Treatment of inflammatory bowel disease |
摘要 |
A method of treating inflammatory bowel disease (IBD) comprises collecting regulatory T cells in an activated or non-activated state from a patient's sentinel lymph nodes draining bowel segments with or without IBD, optionally activating the cells by contacting them with a cytokine and an antigen extract obtained from an inflamed bowel segment, expanding the T cells in vitro, and re-infusing the expanded T cell to the patient. Also disclosed are methods for obtaining sentinel nodes, for expanding T cells, for re-establishing the TH1/TH2 balance in the patient suffering from Crohn's disease, and corresponding uses of the expanded T cells, the cytokine and of antigen extract, as well as of correspondingly activated and expanded T cells. |
申请公布号 |
US8852581(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US200612065047 |
申请日期 |
2006.08.22 |
申请人 |
ITH Immune Therapy Holdings AB |
发明人 |
Winqvist Ola;Thorn Magnus |
分类号 |
A61K35/26;C12N5/0783;A61K35/12 |
主分类号 |
A61K35/26 |
代理机构 |
Johnson, Marcou & Isaacs, LLC |
代理人 |
Griswold Ian J.;Johnson, Marcou & Isaacs, LLC |
主权项 |
1. A method of treating inflammatory bowel disease (IBD) in a human patient, comprising:
injecting a lymphatic staining agent into lesional areas of an intestine of a human patient suffering from IBD, identifying lymphatic tissue stained by the agent as sentinel lymph node draining bowel, isolating regulatory T cells from the sentinel lymph nodes, expanding the collected T cells in vitro in culture medium, contacting the collected T cells with one or more cytokines in combination with an antigen extract obtained from an inflamed bowel segment before, concurrently or after expansion, and re-infusing the expanded T cells to the patient. |
地址 |
Soderkoping SE |